Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

• Xiaoran Yin,
• Yan Feng,
• Bowen Zhang,
• Xueyan Mao,
• Siying Chen,
• Yuyan Wang,
• Sidney W. Fu

Affiliations

Xiaoran Yin

Department of Oncology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China

Yan Feng

Department of Gastroenterology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China

Bowen Zhang

Department of Oncology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China

Xueyan Mao

Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Siying Chen

Department of Pharmacy, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China

Yuyan Wang

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, China

Sidney W. Fu

Division of Cancer Prevention (Cancer Biomarkers Research Group), National Cancer Institute, Rockville, MD, United States